News & Perspective

Mar 14, 2019

Mar 14, 2019
Mycobacterium tuberculosis bacteria

Trial data support shorter drug-resistant TB regimen

Short-course therapy led to a favorable outcome in 79% of patients, compared with 80% in long-course patients.

Feb 08, 2019

Feb 08, 2019

Stewardship / Resistance Scan for Feb 08, 2019

Inadequate TB drug-susceptibility testing
New UK guidance on antibiotics for acute cough

Dec 03, 2018

Dec 03, 2018

News Scan for Dec 03, 2018

Severe Zika thrombocytopenia
Polio outbreak over in Syria
UK vaccine center, more CEPI funds
TB funding climbs

Oct 19, 2018

Oct 19, 2018

Stewardship / Resistance Scan for Oct 19, 2018

Undetected MDR-TB in South Africa
Carbapenem prescribing algorithm

Sep 26, 2018

Sep 26, 2018

News Scan for Sep 26, 2018

Expanded retail info in food recalls
Flu transmission and humidity
Novel pertussis vaccine
Global TB commitment

Sep 18, 2018

Sep 18, 2018
Mycobacterium tuberculosis bacteria

WHO report warns efforts to end TB are falling short

TB remains high in many low- and middle-income nations, and about 558,000 people in 2017 developed rifampicin-resistant TB.

Sep 07, 2018

Sep 07, 2018
Capsules and syringe

Study provides data behind new MDR-TB guidance

Newer and repurposed drugs produced better results and fewer deaths than older treatments did.

Aug 20, 2018

Aug 20, 2018
MDR-TB detection

WHO revises MDR-TB treatment with focus on oral drugs

The changes prioritize newer medications and oral regimens over injectable drugs.

Aug 02, 2018

Aug 02, 2018

News Scan for Aug 02, 2018

Ebola species in DRC
Gaps in school crisis plans
Rat lungworm infection
Longhorned tick in Pennsylvania
Latent TB treatment
Trump's science adviser

Jul 11, 2018

Jul 11, 2018
Tuberculosis in lungs

South African TB study finds lower death rate with bedaquiline

"Our results justify consideration for revised recommendations from WHO and wider use of bedaquiline," the authors write.

Pages

by Topic

by country

by organization

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation 3MAccelerate DiagnosticsGilead 
Grant support for ASP provided by


bioMérieux

  Become an underwriter»